John Libbey Eurotext

European Journal of Dermatology


sQuiz editorial: Latent tuberculosis infection: Update of diagnosis before the introduction of biologic drugs Volume 25, numéro 6, November-December 2015

Dermatology Unit, Complejo Hospitalario Universitario Granada, Spain

Screening of latent tuberculosis infection (LTI) in patients who are going to undergo treatment with biologic drugs (TNF blockers and anti-IL-2/23) to manage moderate-to-severe psoriasis has become an important issue in countries such as Spain, with one of the highest tuberculosis incident rates of Western Europe (13 new cases per 100,000 persons-year, World Health Organization reports) [1]. Interferon-γ Release Assay (IGRA) has recently been introduced as a relevant diagnosis method which could [...]